MASP2 and rheumatoid arthritis: MASP‐2, on the other hand, was sixfold increased in OA SF EVs compared to EVs from RA joints with high‐level inflammation (adj. P‐value = 0.005) and would be consistent with OA SF EVs exerting a pathogenic effect by promoting complement activation in OA.40